Home > > > > Report Detail

Drug Discovery Services Market by Process (Target Selection, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small Molecule, Biologics), Therapeutic Area (Oncology, Neurology, Infectious), End User (Pharma, Biotech, Academic) - Global Forecast to 2028

Publisher Name :
Date: 20-Mar-2023
No. of pages: 347
Inquire Before Buying

Growing R&D Expenditure by pharmaceutical and biopharmaceutical companies is expected to drive the market growth

The global Drug discovery services market is projected to reach USD 41.3 billion by 2028 from USD 20.6 billion in 2023, at a CAGR of 14.9% during the forecast period of 2023 to 2028. Growing R&D expenditure in pharma-biotech sector, increasing drug R&D pipeline and rising reliance on outsourcing, initiatives for research on rare diseases and orphan drugs, and high cost of in-house drug development are expected to provide growth to the market.

Oncology is expected to account for the largest share for therapeutic area segment

Based on therapeutic are the oncology segment has the largest market share. The list of drugs in development for oncology has increased over the years due to the rising number of clinical trials and the growing R&D expenditure by pharmaceutical companies on oncology-based drugs. The incidence of cancer has increased rapidly across the globe. According to GLOBOCAN, the number of new cases is projected to reach 28.9 million by 2040 from 19.3 million in 2020, at a CAGR of ~2% from 2020 to 2040. Owing to this, companies are increasingly focusing on developing novel medicines for cancer; this is expected to drive the growth of this therapeutic segment.

The Hit-to-lead identification segment accounted for the largest share of the process segment in the drug discovery services market

Based on process, the drug discovery services market is broadly classified into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. Hit-to-lead identification segment accounted for the largest share of the drug discovery services market in 2022. Due to its crucial role in the drug discovery process, the hit-to-lead identification is the maximum revenue generating process, and currently many drug discovery companies are specifically offering these services to pharmaceutical companies.

Europe is the second largest region in the drug discovery services market

The drug discovery services market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). After North America, Europe is the second-largest regional pharmaceutical market globally. The research-based pharmaceutical industry can play a critical role in ensuring future competitiveness in an advancing global economy (Source: EFPIA). The development of new chemical and biological molecules, alongside increased R&D activities, will help drive the growth of the drug discovery services market in Europe.

The primary interviews conducted for this report can be categorized as follows:


  • By Respondent: Supply Side- 70% and Demand Side 30%

  • By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%

  • By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, and Middle East and Africa – 5%


Prominent Players of the drug discovery services market are Laboratory Corporation of America Holdings (US), Thermo Fisher Scientific Inc. (US), Charles River Laboratories International, Inc. (US), WuXi AppTec (China), Eurofins Scientific SE (Germany), Evotec SE (Germany), Syngene International Limited (India), Curia Global Inc. (US), Dr. Reddy Laboratories Ltd. (Aurigene Discovery Technologies) (India), Pharmaron Beijing Co., Ltd. (China), Piramal Enterprises Limited (India)

Research Coverage:

This report provides a detailed picture of thedrug discoverymarket. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall drug discovery market and its sub segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers:


  • Analysis of key drivers (Growing R&D expenditure in pharma-biotech sector, Increasing drug R&D pipeline and rising reliance on outsourcing, Initiatives for research on rare diseases and orphan drugs, and High cost of in-house drug development), restraints(Stringent regulations governing drug discovery and animal usage), opportunities (Technological advancements and new drug discovery techniques, Rising demand for specialized testing services among end users, Patent expiries of key biologics, and High growth prospects in emerging markets), and challenges (Shortage of skilled personnel) influencing the growth of drug discovery services market.

  • Service Development/Innovation: Detailed insights on newly launched services, and technological assessment of the drug discovery market.

  • Market Development: Comprehensive information about lucrative markets – the report analyses the drug discovery services market across varied regions.

  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the drug discovery services market.

  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Laboratory Corporation of America Holdings (US), Thermo Fisher Scientific Inc. (US), Charles River Laboratories International, Inc. (US), WuXi AppTec (China) among others in the drug discovery services market. The report also helps stakeholders understand the pulse of drug discovery services market and provides them information on key market drivers, restraints, challenges, and opportunities.

Drug Discovery Services Market by Process (Target Selection, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small Molecule, Biologics), Therapeutic Area (Oncology, Neurology, Infectious), End User (Pharma, Biotech, Academic) - Global Forecast to 2028

Table Of Contents

1 Introduction 43
1.1 Study Objectives 43
1.2 Market Definition 43
1.2.1 Inclusions And Exclusions 43
1.3 Market Scope 44
1.3.1 Markets Covered 44
1.4 Years Considered 44
1.5 Currency Considered 45
1.6 Limitations 45
1.7 Stakeholders 45
1.8 Summary Of Changes 46
1.8.1 Recession Impact 46

2 Research Methodology 47
2.1 Research Data 47
Figure 1 Research Design 47
2.1.1 Secondary Data 48
2.1.2 Primary Data 49
Figure 2 Drug Discovery Services Market: Breakdown Of Primaries 49
2.2 Market Estimation Methodology 50
Figure 3 Drug Discovery Services Market Size Estimation(Supply-Side Analysis), 2022 50
Figure 4 Market Size Estimation: Approach 1 (Company Revenue Analysis-Based Estimation), 2022 51
Figure 5 Illustrative Example Of Company Revenue Analysis, 2022 52
2.2.1 Insights From Primary Experts 53
Figure 6 Market Size Validation From Primary Sources 53
2.3 Market Growth Rate Projections 54
Figure 7 Drug Discovery Services Market (Supply-Side): Cagr Projections 55
Figure 8 Drug Discovery Services Market (Demand-Side): Growth Analysis Of Demand-Side Drivers 55
2.4 Market Breakdown And Data Triangulation 56
Figure 9 Data Triangulation Methodology 56
2.5 Research Assumptions 57
2.6 Risk Analysis 57
2.7 Recession Impact Analysis 57
Table 1 Global Inflation Rate Projections, 2021–2027 (% Growth) 58
Table 2 Us Health Expenditure, 2019–2022 (Usd Million) 58
Table 3 Us Health Expenditure, 2023–2027 (Usd Million) 58

3 Executive Summary 59
Figure 10 Drug Discovery Services Market, By Type, 2023 Vs. 2028 (Usd Million) 59
Figure 11 Drug Discovery Services Market, By Process,2023 Vs. 2028 (Usd Million) 60
Figure 12 Drug Discovery Services Market, By Therapeutic Area,2023 Vs. 2028 (Usd Million) 60
Figure 13 Drug Discovery Services Market, By End User,2023 Vs. 2028 (Usd Million) 61
Figure 14 Geographical Snapshot Of Drug Discovery Services Market, 2022 62

4 Premium Insights 63
4.1 Drug Discovery Services Market Overview 63
Figure 15 Increasing R&D Expenditure In Pharmaceutical And Biopharmaceutical Industry To Drive Market Growth 63
4.2 North America: Drug Discovery Services Market,By Drug Type And Country (2022) 64
Figure 16 Small-Molecule Drugs Held Largest Share Of North American Drug Discovery Market In 2022 64
4.3 Drug Discovery Services Market Share, By Type (2022) 64
Figure 17 Chemistry Services Segment Accounted For Largest Market Sharein 2022 64
4.4 Drug Discovery Services Market: Geographic Growth Opportunities 65
Figure 18 Asia Pacific Countries To Register Highest Growth From 2023–2028 65

5 Market Overview 66
5.1 Introduction 66
5.2 Market Dynamics 66
Figure 19 Drug Discovery Services Market: Drivers, Restraints, Opportunities, And Challenges 66
Table 4 Drug Discovery Services Market: Impact Analysis 67
5.2.1 Drivers 67
5.2.1.1 Growing R&D Expenditure In Pharma-Biotech Sector 67
Figure 20 Rising Global Pharmaceutical R&D Spending, 2014–2028 68
5.2.1.2 Increasing Drug R&D Pipeline And Rising Reliance On Outsourcing 68
Figure 21 Active Pharmaceutical Pipeline, 2012–2022 69
5.2.1.3 Initiatives For Research On Rare Diseases And Orphan Drugs 69
Figure 22 Number Of Drugs Given Orphan Drug Status (2013–2021) 70
5.2.1.4 High Cost Of In-House Drug Development 70
Figure 23 Average Cost To Develop A Pharmaceutical Compound From Discovery To Launch, 2010–2020 (Usd Billion) 71
5.2.2 Restraints 71
5.2.2.1 Stringent Regulations Governing Drug Discovery And Animal Usage 71
5.2.3 Opportunities 72
5.2.3.1 Technological Advancements And New Drug Discovery Techniques 72
5.2.3.2 Rising Demand For Specialized Testing Services Among End Users 72
5.2.3.3 Patent Expiries Of Key Biologics 73
Table 5 Us: Biologics Going Off-Patent During 2023–2027 73
5.2.3.4 High Growth Prospects In Emerging Markets 74
5.2.4 Challenges 74
5.2.4.1 Shortage Of Skilled Personnel 74
5.2.5 Market Trends 75
5.2.5.1 Adoption Of Ai In Drug Discovery 75
5.2.5.2 Increased Outsourcing To Emerging Asian Economies 76
5.2.5.3 Cro Industry Consolidation 77
Table 6 Drug Discovery Services Market: Prominent Acquisitions, 2023–2021 77
5.2.5.4 Integrated End-To-End R&D Service Offerings 78
5.3 Ranges/Scenarios 79
Figure 24 Spectrum Of Scenarios Based On Impact Of Uncertainties Ondrug Discovery Services Market Growth 79
5.4 Trends/Disruptions Impacting Customer Businesses 80
Figure 25 Revenue Shift And New Pockets For Drug Discovery Service Providers 80
5.5 Value Chain Analysis 81
Figure 26 Value Chain Analysis Of Drug Discovery Services Market: Hit-To-Lead Identification And Lead Optimization Phases Add Maximum Value 81
5.6 Ecosystem Analysis 82
Figure 27 Ecosystem Analysis: Drug Discovery Services Market 82
Table 7 Supply Chain Ecosystem 83
5.7 Technology Analysis 84
5.8 Pricing Analysis 86
5.8.1 Average Selling Price Trend Analysis 86
Table 8 Drug Discovery And Development Process & Cost Overview (2018 Vs 2022) 86
5.9 Regulatory Analysis 87
5.9.1 Regulatory Bodies, Government Agencies,And Other Organizations 87
Table 9 North America: Regulatory Bodies, Government Agencies,And Other Organizations 87
Table 10 Europe: Regulatory Bodies, Government Agencies, And Other Organizations 88
Table 11 Asia Pacific: Regulatory Bodies, Government Agencies,And Other Organizations 88
Table 12 Row: Regulatory Bodies, Government Agencies, And Other Organizations 89
5.10 Porter’s Five Forces Analysis 89
Table 13 Drug Discovery Services Market: Porter’s Five Forces Analysis 89
5.10.1 Threat Of New Entrants 89
5.10.2 Threat Of Substitutes 90
5.10.3 Bargaining Power Of Buyers 90
5.10.4 Bargaining Power Of Suppliers 90
5.10.5 Intensity Of Competitive Rivalry 90
5.11 Key Conferences & Events, 2022–2023 91
Table 14 Drug Discovery Services Market: Detailed List Of Conferences & Events 91
5.12 Key Stakeholders & Buying Criteria 92
5.12.1 Key Stakeholders In Buying Process 92
Figure 28 Influence Of Stakeholders On Buying Process Of Drug Discovery Services 92
5.12.2 Buying Criteria For Drug Discovery Services 92
Figure 29 Key Buying Criteria For End Users 92

6 Drug Discovery Services Market, By Process 93
6.1 Introduction 94
Table 15 Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 94
6.2 Target Selection 95
6.2.1 Development Of New Technologies To Support Market Growth 95
Table 16 Drug Discovery Services Market For Target Selection, By Region,2021–2028 (Usd Million) 96
Table 17 North America: Drug Discovery Services Market For Target Selection,By Country, 2021–2028 (Usd Million) 96
Table 18 Europe: Drug Discovery Services Market For Target Selection, By Country,2021–2028 (Usd Million) 96
Table 19 Asia Pacific: Drug Discovery Services Market For Target Selection,By Country, 2021–2028 (Usd Million) 97
Table 20 Latin America: Drug Discovery Services Market For Target Selection,By Country, 2021–2028 (Usd Million) 97
6.3 Target Validation 97
6.3.1 Emphasis On Target Validation To Avoid Late-Stage Failure To Promote Market Growth 97
Table 21 Drug Discovery Services Market For Target Validation, By Region,2021–2028 (Usd Million) 98
Table 22 North America: Drug Discovery Services Market For Target Validation,By Country, 2021–2028 (Usd Million) 98
Table 23 Europe: Drug Discovery Services Market For Target Validation, By Country,2021–2028 (Usd Million) 99
Table 24 Asia Pacific: Drug Discovery Services Market For Target Validation,By Country, 2021–2028 (Usd Million) 99
Table 25 Latin America: Drug Discovery Services Market For Target Validation,By Country, 2021–2028 (Usd Million) 100
6.4 Hit-To-Lead Identification 100
6.4.1 Hit-To-Lead Identification To Hold Largest Market Share 100
Table 26 Drug Discovery Services Market For Hit-To-Lead Identification, By Region,2021–2028 (Usd Million) 101
Table 27 North America: Drug Discovery Services Market For Hit-To-Lead Identification, By Country, 2021–2028 (Usd Million) 101
Table 28 Europe: Drug Discovery Services Market For Hit-To-Lead Identification, By Country, 2021–2028 (Usd Million) 102
Table 29 Asia Pacific: Drug Discovery Services Market For Hit-To-Lead Identification,By Country, 2021–2028 (Usd Million) 102
Table 30 Latin America: Drug Discovery Services Market For Hit-To-Lead Identification,By Country, 2021–2028 (Usd Million) 103
6.5 Lead Optimization 103
6.5.1 Need For Transparent Presentation And Analysis To Boost Focus On Lead Optimization 103
Table 31 Drug Discovery Services Market For Lead Optimization, By Region,2021–2028 (Usd Million) 104
Table 32 North America: Drug Discovery Services Market For Lead Optimization,By Country, 2021–2028 (Usd Million) 104
Table 33 Europe: Drug Discovery Services Market For Lead Optimization, By Country,2021–2028 (Usd Million) 104
Table 34 Asia Pacific: Drug Discovery Services Market For Lead Optimization,By Country, 2021–2028 (Usd Million) 105
Table 35 Latin America: Drug Discovery Services Market For Lead Optimization,By Country, 2021–2028 (Usd Million) 105
6.6 Candidate Validation 105
6.6.1 Possibility Of Drug Failure During Development To Drive Adoption Of Candidate Validation Services 105
Table 36 Drug Discovery Services Market For Candidate Validation, By Region,2021–2028 (Usd Million) 106
Table 37 North America: Drug Discovery Services Market For Candidate Validation,By Country, 2021–2028 (Usd Million) 106
Table 38 Europe: Drug Discovery Services Market For Candidate Validation,By Country, 2021–2028 (Usd Million) 107
Table 39 Asia Pacific: Drug Discovery Services Market For Candidate Validation,By Country, 2021–2028 (Usd Million) 107
Table 40 Latin America: Drug Discovery Services Market For Candidate Validation,By Country, 2021–2028 (Usd Million) 108

7 Drug Discovery Services Market, By Type 109
7.1 Introduction 110
Table 41 Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 110
7.2 Chemistry Services 110
7.2.1 Chemistry Services To Dominate Service Type Market 110
Table 42 Chemistry Services Market, By Region, 2021–2028 (Usd Million) 111
Table 43 North America: Chemistry Services Market, By Country,2021–2028 (Usd Million) 111
Table 44 Europe: Chemistry Services Market, By Country, 2021–2028 (Usd Million) 111
Table 45 Asia Pacific: Chemistry Services Market, By Country, 2021–2028 (Usd Million) 112
Table 46 Latin America: Chemistry Services Market, By Country,2021–2028 (Usd Million) 112
7.3 Biology Services 112
7.3.1 Restrictions On Animal Usage To Slow Market Growth 112
Table 47 Biology Services Market, By Region, 2021–2028 (Usd Million) 113
Table 48 North America: Biology Services Market, By Country,2021–2028 (Usd Million) 114
Table 49 Europe: Biology Services Market, By Country, 2021–2028 (Usd Million) 114
Table 50 Asia Pacific: Biology Services Market, By Country, 2021–2028 (Usd Million) 114
Table 51 Latin America: Biology Services Market, By Country, 2021–2028 (Usd Million) 115

8 Drug Discovery Services Market, By Drug Type 116
8.1 Introduction 117
Table 52 Drug Discovery Services Market, By Drug Type, 2021–2028 (Usd Million) 117
8.2 Small-Molecule Drugs 117
8.2.1 Small-Molecule Drugs To Hold Largest Market Share 117
Table 53 Drug Discovery Services Market For Small-Molecule Drugs, By Region, 2021–2028 (Usd Million) 118
Table 54 North America: Drug Discovery Services Market For Small-Molecule Drugs, By Country, 2021–2028 (Usd Million) 118
Table 55 Europe: Drug Discovery Services Market For Small-Molecule Drugs,By Country, 2021–2028 (Usd Million) 119
Table 56 Asia Pacific: Drug Discovery Services Market For Small-Molecule Drugs,By Country, 2021–2028 (Usd Million) 119
Table 57 Latin America: Drug Discovery Services Market For Small-Molecule Drugs,By Country, 2021–2028 (Usd Million) 120
8.3 Biologics 120
8.3.1 Market Growth Of Biologics & Challenges Associated With Discovery To Drive Adoption Of Outsourcing Services 120
Table 58 Drug Discovery Services Market For Biologics, By Region,2021–2028 (Usd Million) 121
Table 59 North America: Drug Discovery Services Market For Biologics,By Country, 2021–2028 (Usd Million) 121
Table 60 Europe: Drug Discovery Services Market For Biologics, By Country,2021–2028 (Usd Million) 122
Table 61 Asia Pacific: Drug Discovery Services Market For Biologics,By Country, 2021–2028 (Usd Million) 122
Table 62 Latin America: Drug Discovery Services Market For Biologics,By Country, 2021–2028 (Usd Million) 123

9 Drug Discovery Services Market, By Therapeutic Area 124
9.1 Introduction 125
Table 63 Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 125
9.2 Oncology 126
9.2.1 High And Growing Number Of Research Studies On Cancer Therapeutics To Support Market Growth 126
Figure 30 Number Of Oncology Clinical Trials, 2012–2022 (Thousand) 126
Table 64 List Of Fda Drugs Approved For Oncology (2022) 127
Table 65 Drug Discovery Services Market For Oncology, By Region,2021–2028 (Usd Million) 127
Table 66 North America: Drug Discovery Services Market For Oncology, By Country, 2021–2028 (Usd Million) 128
Table 67 Europe: Drug Discovery Services Market For Oncology, By Country,2021–2028 (Usd Million) 128
Table 68 Asia Pacific: Drug Discovery Services Market For Oncology, By Country, 2021–2028 (Usd Million) 129
Table 69 Latin America: Drug Discovery Services Market For Oncology, By Country, 2021–2028 (Usd Million) 129
9.3 Infectious Diseases 129
9.3.1 Rising Epidemic Outbreaks To Boost Drug Discovery Activity 129
Table 70 Drug Discovery Services Market For Infectious Diseases, By Region,2021–2028 (Usd Million) 130
Table 71 North America Drug Discovery Services Market For Infectious Diseases,By Country, 2021–2028 (Usd Million) 130
Table 72 Europe: Drug Discovery Services Market For Infectious Diseases,By Country, 2021–2028 (Usd Million) 131
Table 73 Asia Pacific: Drug Discovery Services Market For Infectious Diseases,By Country, 2021–2028 (Usd Million) 131
Table 74 Latin America: Drug Discovery Services Market For Infectious Diseases,By Country, 2021–2028 (Usd Million) 132
9.4 Cardiovascular Diseases 132
9.4.1 High Mortality Rates Prompting Pharmaceutical Companies To Develop New Treatment Options 132
Table 75 List Of Pipeline Drugs For Cardiovascular Diseases (As Of December 2022) 132
Table 76 Drug Discovery Services Market For Cardiovascular Diseases, By Region, 2021–2028 (Usd Million) 133
Table 77 North America: Drug Discovery Services Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 133
Table 78 Europe: Drug Discovery Services Market For Cardiovascular Diseases,By Country, 2021–2028 (Usd Million) 134
Table 79 Asia Pacific: Drug Discovery Services Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 134
Table 80 Latin America: Drug Discovery Services Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 135
9.5 Neurological Diseases 135
9.5.1 Increasing Investments In R&D For Neurological Disorders To Drive Market 135
Table 81 List Of Pipeline Drugs For Neurological Disorders (2022) 136
Table 82 Drug Discovery Services Market For Neurological Diseases, By Region,2021–2028 (Usd Million) 136
Table 83 North America: Drug Discovery Services Market For Neurological Diseases, By Country, 2021–2028 (Usd Million) 136
Table 84 Europe: Drug Discovery Services Market For Neurological Diseases,By Country, 2021–2028 (Usd Million) 137
Table 85 Asia Pacific: Drug Discovery Services Market For Neurological Diseases,By Country, 2021–2028 (Usd Million) 137
Table 86 Latin America:Drug Discovery Services Market For Neurological Diseases, By Country, 2021–2028 (Usd Million) 138
9.6 Immunological Disorders 138
9.6.1 Growing Drug Pipeline For Immunological Disorders To Favor Market Growth 138
Table 87 List Of Pipeline Drugs For Immunological Disorders (2022) 138
Table 88 Drug Discovery Services Market For Immunological Disorders, By Region, 2021–2028 (Usd Million) 139
Table 89 North America: Drug Discovery Services Market For Immunological Disorders, By Country, 2021–2028 (Usd Million) 139
Table 90 Europe: Drug Discovery Services Market For Immunological Disorders,By Country, 2021–2028 (Usd Million) 139
Table 91 Asia Pacific: Drug Discovery Services Market For Immunological Disorders, By Country, 2021–2028 (Usd Million) 140
Table 92 Latin America:Drug Discovery Services Market For Immunological Disorders, By Country, 2021–2028 (Usd Million) 140
9.7 Endocrine & Metabolic Disorders 140
9.7.1 Increasing Diabetic Population To Boost Market 140
Figure 31 Estimated Number Of Individuals With Diabetes, 2000–2045 (Million) 141
Table 93 Drug Discovery Services Market For Endocrine & Metabolic Disorders,By Region, 2021–2028 (Usd Million) 142
Table 94 North America: Drug Discovery Services Market For Endocrine & Metabolic Disorders, By Country, 2021–2028 (Usd Million) 142
Table 95 Europe: Drug Discovery Services Market For Endocrine & Metabolic Disorders, By Country, 2021–2028 (Usd Million) 142
Table 96 Asia Pacific: Drug Discovery Services Market For Endocrine & Metabolic Disorders, By Country, 2021–2028 (Usd Million) 143
Table 97 Latin America: Drug Discovery Services Market For Endocrine & Metabolic Disorders, By Country, 2021–2028 (Usd Million) 143
9.8 Respiratory Disorders 143
9.8.1 Rising Burden Of Respiratory Disorders To Support Growth 143
Table 98 List Of Pipeline Drugs For Respiratory Disorders (2022) 144
Table 99 Drug Discovery Services Market For Respiratory Disorders, By Region,2021–2028 (Usd Million) 144
Table 100 North America: Drug Discovery Services Market For Respiratory Disorders, By Country, 2021–2028 (Usd Million) 145
Table 101 Europe: Drug Discovery Services Market For Respiratory Disorders,By Country, 2021–2028 (Usd Million) 145
Table 102 Asia Pacific: Drug Discovery Services Market For Respiratory Disorders,By Country, 2021–2028 (Usd Million) 145
Table 103 Latin America: Drug Discovery Services Market For Respiratory Disorders, By Country, 2021–2028 (Usd Million) 146
9.9 Digestive System Diseases 146
9.9.1 Rising Disease Incidence Due To Lifestyle And Dietary Changes To Propel Market 146
Table 104 Drug Discovery Services Market For Digestive System Diseases, By Region, 2021–2028 (Usd Million) 147
Table 105 North America: Drug Discovery Services Market For Digestive System Diseases, By Country, 2021–2028 (Usd Million) 147
Table 106 Europe: Drug Discovery Services Market For Digestive System Diseases,By Country, 2021–2028 (Usd Million) 147
Table 107 Asia Pacific: Drug Discovery Services Market For Digestive System Diseases, By Country, 2021–2028 (Usd Million) 148
Table 108 Latin America: Drug Discovery Services Market For Digestive System Diseases, By Country, 2021–2028 (Usd Million) 148
9.10 Genitourinary Diseases & Women’s Health 148
9.10.1 Rising Prevalence Of Chronic Disorders In Women To Boost Market 148
Table 109 Drug Discovery Services Market For Genitourinary Diseases & Women’s Health, By Region, 2021–2028 (Usd Million) 149
Table 110 North America: Drug Discovery Services Market For Genitourinary Diseases & Women’s Health, By Country, 2021–2028 (Usd Million) 149
Table 111 Europe: Drug Discovery Services Market For Genitourinary Diseases & Women’s Health, By Country, 2021–2028 (Usd Million) 150
Table 112 Asia Pacific: Drug Discovery Services Market For Genitourinary Diseases & Women’s Health, By Country, 2021–2028 (Usd Million) 150
Table 113 Latin America: Drug Discovery Services Market For Genitourinary Diseases & Women’s Health, By Country, 2021–2028 (Usd Million) 151
9.11 Other Therapeutic Areas 151
Table 114 Drug Discovery Services Market For Other Therapeutic Areas, By Region,2021–2028 (Usd Million) 152
Table 115 North America: Drug Discovery Services Market For Other Therapeutic Areas, By Country, 2021–2028 (Usd Million) 152
Table 116 Europe: Drug Discovery Services Market For Other Therapeutic Areas,By Country, 2021–2028 (Usd Million) 153
Table 117 Asia Pacific: Drug Discovery Services Market For Other Therapeutic Areas,By Country, 2021–2028 (Usd Million) 153
Table 118 Latin America: Drug Discovery Services Market For Other Therapeutic Areas, By Country, 2021–2028 (Usd Million) 154

10 Drug Discovery Services Market, By End User 155
10.1 Introduction 156
Table 119 Drug Discovery Services Market, By End User, 2021–2028 (Usd Million) 156
10.2 Pharmaceutical & Biotechnology Companies 156
Figure 32 R&D Spending Of Phrma Member Companies, 2011–2021 157
Table 120 Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Region, 2021–2028 (Usd Million) 157
Table 121 North America: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 158
Table 122 Europe: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 158
Table 123 Asia Pacific: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 158
Table 124 Latin America: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2021–2028 (Usd Million) 159
10.2.1 Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type 159
Table 125 Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 159
10.2.2 Tier 1 Companies 159
10.2.2.1 High Investing Capacity To Drive Growth 159
Table 126 Top Pharma Companies, By Revenue (2022) 160
Table 127 Drug Discovery Services Market For Tier 1 Companies, By Region,2021–2028 (Usd Million) 160
Table 128 North America: Drug Discovery Services Market For Tier 1 Companies,By Country, 2021–2028 (Usd Million) 160
Table 129 Europe: Drug Discovery Services Market For Tier 1 Companies, By Country, 2021–2028 (Usd Million) 161
Table 130 Asia Pacific: Drug Discovery Services Market For Tier 1 Companies,By Country, 2021–2028 (Usd Million) 161
Table 131 Latin America: Drug Discovery Services Market For Tier 1 Companies,By Country, 2021–2028 (Usd Million) 162
10.2.3 Tier 2 Companies 162
10.2.3.1 Limited Investment Capacity To Slow Market Growth 162
Table 132 Drug Discovery Services Market For Tier 2 Companies, By Region,2021–2028 (Usd Million) 162
Table 133 North America: Drug Discovery Services Market For Tier 2 Companies,By Country, 2021–2028 (Usd Million) 163
Table 134 Europe: Drug Discovery Services Market For Tier 2 Companies, By Country, 2021–2028 (Usd Million) 163
Table 135 Asia Pacific: Drug Discovery Services Market For Tier 2 Companies,By Country, 2021–2028 (Usd Million) 163
Table 136 Latin America: Drug Discovery Services Market For Tier 2 Companies,By Country, 2021–2028 (Usd Million) 164
10.2.4 Tier 3 Companies 164
10.2.4.1 Insufficient Technical Advantages To Restrain Growth 164
Table 137 Drug Discovery Services Market For Tier 3 Companies, By Region,2021–2028 (Usd Million) 164
Table 138 North America: Drug Discovery Services Market For Tier 3 Companies,By Country, 2021–2028 (Usd Million) 165
Table 139 Europe: Drug Discovery Services Market For Tier 3 Companies, By Country, 2021–2028 (Usd Million) 165
Table 140 Asia Pacific: Drug Discovery Services Market For Tier 3 Companies,By Country, 2021–2028 (Usd Million) 165
Table 141 Latin America: Drug Discovery Services Market For Tier 3 Companies,By Country, 2021–2028 (Usd Million) 166
10.3 Academic Institutes 166
10.3.1 Collaboration With Market Players To Provide More Flexible And Efficient Pathways For Clinical Development 166
Table 142 Drug Discovery Services Market For Academic Institutes, By Region,2021–2028 (Usd Million) 167
Table 143 North America: Drug Discovery Services Market For Academic Institutes,By Country, 2021–2028 (Usd Million) 167
Table 144 Europe: Drug Discovery Services Market For Academic Institutes,By Country, 2021–2028 (Usd Million) 167
Table 145 Asia Pacific: Drug Discovery Services Market For Academic Institutes,By Country, 2021–2028 (Usd Million) 168
Table 146 Latin America: Drug Discovery Services Market For Academic Institutes,By Country, 2021–2028 (Usd Million) 168
10.4 Other End Users 168
Table 147 Drug Discovery Services Market For Other End Users, By Region,2021–2028 (Usd Million) 169
Table 148 North America: Drug Discovery Services Market For Other End Users,By Country, 2021–2028 (Usd Million) 169
Table 149 Europe: Drug Discovery Services Market For Other End Users, By Country, 2021–2028 (Usd Million) 170
Table 150 Asia Pacific: Drug Discovery Services Market For Other End Users,By Country, 2021–2028 (Usd Million) 170
Table 151 Latin America: Drug Discovery Services Market For Other End Users,By Country, 2021–2028 (Usd Million) 171

11 Drug Discovery Services Market, By Region 172
11.1 Introduction 173
Table 152 Drug Discovery Services Market, By Region, 2021–2028 (Usd Million) 173
11.2 North America 174
Figure 33 North America: Drug Discovery Services Market Snapshot (2022) 175
Table 153 North America: Drug Discovery Services Market, By Country,2021–2028 (Usd Million) 176
Table 154 North America: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 176
Table 155 North America: Drug Discovery Services Market, By Type,2021–2028 (Usd Million) 176
Table 156 North America: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 177
Table 157 North America: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 177
Table 158 North America: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 178
Table 159 North America: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 178
11.2.1 Us 178
11.2.1.1 Us To Dominate North American Market 178
Figure 34 Distribution Of R&D Companies, By Country/Region (2021 Vs. 2022) 179
Table 160 Us: Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 179
Table 161 Us: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 180
Table 162 Us: Drug Discovery Services Market, By Drug Type, 2021–2028 (Usd Million) 180
Table 163 Us: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 181
Table 164 Us: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 181
Table 165 Us: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 182
11.2.2 Canada 182
11.2.2.1 Growing Preference To Conduct Clinical Trials In Canada To Support Market Growth 182
Table 166 Canada: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 183
Table 167 Canada: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 183
Table 168 Canada: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 183
Table 169 Canada: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 184
Table 170 Canada: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 184
Table 171 Canada: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 185
11.2.3 North America: Recession Impact 185
11.3 Europe 186
Table 172 Europe: Drug Discovery Services Market, By Country,2021–2028 (Usd Million) 186
Table 173 Europe: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 187
Table 174 Europe: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 187
Table 175 Europe: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 187
Table 176 Europe: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 188
Table 177 Europe: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 188
Table 178 Europe: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 189
11.3.1 Germany 189
11.3.1.1 Germany To Hold Largest Share Of European Market 189
Table 179 Germany: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 190
Table 180 Germany: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 190
Table 181 Germany: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 190
Table 182 Germany: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 191
Table 183 Germany: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 191
Table 184 Germany: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 192
11.3.2 Uk 192
11.3.2.1 Government-Private Sector Collaborations To Boost Market 192
Table 185 Uk: Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 193
Table 186 Uk: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 193
Table 187 Uk: Drug Discovery Services Market, By Drug Type, 2021–2028 (Usd Million) 193
Table 188 Uk: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 194
Table 189 Uk: Drug Discovery Services Market, By End User, 2021–2028 (Usd Million) 194
Table 190 Uk: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 195
11.3.3 France 195
11.3.3.1 Growing Number Of Oncology Research Projects To Propel Market 195
Table 191 France: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 196
Table 192 France: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 196
Table 193 France: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 196
Table 194 France: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 197
Table 195 France: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 197
Table 196 France: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 198
11.3.4 Italy 198
11.3.4.1 High Number Of Clinical Trials And Low Drug Approval Time To Augment Market 198
Table 197 Number Of Clinical Trials In Italy, By Company (January 2022) 199
Table 198 Italy: Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 199
Table 199 Italy: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 199
Table 200 Italy: Drug Discovery Services Market, By Drug Type, 2021–2028 (Usd Million) 200
Table 201 Italy: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 200
Table 202 Italy: Drug Discovery Services Market, By End User, 2021–2028 (Usd Million) 201
Table 203 Italy: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 201
11.3.5 Spain 201
11.3.5.1 Short Study Start-Up Times And Rising R&D Expenditure To Augment Market 201
Table 204 Spain: Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 202
Table 205 Spain: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 202
Table 206 Spain: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 203
Table 207 Spain: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 203
Table 208 Spain: Drug Discovery Services Market, By End User, 2021–2028 (Usd Million) 204
Table 209 Spain: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 204
11.3.6 Rest Of Europe 204
Table 210 Rest Of Europe: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 205
Table 211 Rest Of Europe: Drug Discovery Services Market, By Type,2021–2028 (Usd Million) 206
Table 212 Rest Of Europe: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 206
Table 213 Rest Of Europe: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 207
Table 214 Rest Of Europe: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 207
Table 215 Rest Of Europe: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 208
11.3.7 Europe: Recession Impact 208
11.4 Asia Pacific 209
Figure 35 Apac: Drug Discovery Services Market Snapshot (2022) 210
Table 216 Asia Pacific: Drug Discovery Services Market, By Country,2021–2028 (Usd Million) 211
Table 217 Asia Pacific: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 211
Table 218 Asia Pacific: Drug Discovery Services Market, By Type,2021–2028 (Usd Million) 212
Table 219 Asia Pacific: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 212
Table 220 Asia Pacific: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 213
Table 221 Asia Pacific: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 213
Table 222 Asia Pacific: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 214
11.4.1 China 214
11.4.1.1 Robust Pharma Industry And Presence Of Key Cros To Account For China’s Large Market Share 214
Table 223 China: Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 215
Table 224 China: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 215
Table 225 China: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 215
Table 226 China: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 216
Table 227 China: Drug Discovery Services Market, By End User, 2021–2028 (Usd Million) 216
Table 228 China: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 217
11.4.2 Japan 217
11.4.2.1 Government Initiatives For Drug Innovation To Support Market Growth 217
Table 229 Total Number Of Clinical Trials In Japan, By Therapeutic Area, 2020 Vs. 2022 218
Table 230 Japan: Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 218
Table 231 Japan: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 218
Table 232 Japan: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 219
Table 233 Japan: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 219
Table 234 Japan: Drug Discovery Services Market, By End User, 2021–2028 (Usd Million) 220
Table 235 Japan: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 220
11.4.3 India 220
11.4.3.1 Low-Cost Services, Availability Of Skilled Workforce, And Strong Government Support To Propel Market 220
Table 236 India: Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 221
Table 237 India: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 221
Table 238 India: Drug Discovery Services Market, By Drug Type, 2021–2028 (Usd Million) 222
Table 239 India: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 222
Table 240 India: Drug Discovery Services Market, By End User, 2021–2028 (Usd Million) 223
Table 241 India: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 223
11.4.4 Australia 223
11.4.4.1 Large Number Of Clinical Trials To Make Australia A Favorable Location For Drug Discovery 223
Table 242 Australia: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 224
Table 243 Australia: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 224
Table 244 Australia: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 225
Table 245 Australia: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 225
Table 246 Australia: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 226
Table 247 Australia: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 226
11.4.5 South Korea 226
11.4.5.1 Government Initiatives And Growing R&D Activities For Drug Development To Drive Growth 226
Table 248 South Korea: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 227
Table 249 South Korea: Drug Discovery Services Market, By Type,2021–2028 (Usd Million) 227
Table 250 South Korea: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 227
Table 251 South Korea: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 228
Table 252 South Korea: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 228
Table 253 South Korea: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 229
11.4.6 Rest Of Asia Pacific 229
Table 254 Rest Of Asia Pacific: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 229
Table 255 Rest Of Asia Pacific: Drug Discovery Services Market, By Type,2021–2028 (Usd Million) 230
Table 256 Rest Of Asia Pacific: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 230
Table 257 Rest Of Asia Pacific: Drug Discovery Services Market, By Therapeutic Area, 2021–2028 (Usd Million) 231
Table 258 Rest Of Asia Pacific: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 231
Table 259 Rest Of Asia Pacific: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 232
11.4.7 Asia Pacific: Recession Impact 232
11.5 Latin America 233
Table 260 Latin America: Drug Discovery Services Market, By Country,2021–2028 (Usd Million) 233
Table 261 Latin America: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 233
Table 262 Latin America: Drug Discovery Services Market, By Type,2021–2028 (Usd Million) 234
Table 263 Latin America: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 234
Table 264 Latin America: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 235
Table 265 Latin America: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 235
Table 266 Latin America: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 236
11.5.1 Brazil 236
11.5.1.1 Brazil To Dominate Latin American Market 236
Table 267 Brazil: Drug Discovery Services Market, By Process, 2021–2028 (Usd Million) 236
Table 268 Brazil: Drug Discovery Services Market, By Type, 2021–2028 (Usd Million) 237
Table 269 Brazil: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 237
Table 270 Brazil: Drug Discovery Services Market, By Therapeutic Area,2021–2028 (Usd Million) 238
Table 271 Brazil: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 238
Table 272 Brazil: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 239
11.5.2 Rest Of Latin America 239
Table 273 Rest Of Latin America: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 239
Table 274 Rest Of Latin America: Drug Discovery Services Market, By Type,2021–2028 (Usd Million) 240
Table 275 Rest Of Latin America: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 240
Table 276 Rest Of Latin America: Drug Discovery Services Market, By Therapeutic Area, 2021–2028 (Usd Million) 241
Table 277 Rest Of Latin America: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 241
Table 278 Rest Of Latin America: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 242
11.5.3 Latin America: Recession Impact 242
11.6 Middle East & Africa 242
11.6.1 Growing Pharmaceutical Industry To Boost Market 242
Table 279 Middle East & Africa: Drug Discovery Services Market, By Process,2021–2028 (Usd Million) 243
Table 280 Middle East & Africa: Drug Discovery Services Market, By Type,2021–2028 (Usd Million) 243
Table 281 Middle East & Africa: Drug Discovery Services Market, By Drug Type,2021–2028 (Usd Million) 243
Table 282 Middle East & Africa: Drug Discovery Services Market, By Therapeutic Area, 2021–2028 (Usd Million) 244
Table 283 Middle East & Africa: Drug Discovery Services Market, By End User,2021–2028 (Usd Million) 244
Table 284 Middle East & Africa: Drug Discovery Services Market For Pharmaceutical & Biotechnology Companies, By Type, 2021–2028 (Usd Million) 245
11.6.2 Middle East & Africa: Recession Impact 245

12 Competitive Landscape 246
12.1 Overview 246
12.2 Key Strategies Adopted By Major Players 247
Figure 36 Key Strategies Adopted By Players In Drug Discovery Services Market, 2020–2023 247
12.3 Market Share Analysis 248
Figure 37 Drug Discovery Services Market: Market Share Analysis,By Key Player, 2022 248
Table 285 Drug Discovery Services Market: Degree Of Competition 248
12.4 Revenue Share Analysis Of The Top Market Players 249
Figure 38 Revenue Share Analysis Of Top Players, 2020–2022 249
12.5 Company Evaluation Quadrant 250
12.5.1 Stars 250
12.5.2 Emerging Leaders 250
12.5.3 Pervasive Players 250
12.5.4 Participants 250
Figure 39 Drug Discovery Services Market: Company Evaluation Quadrant, 2022 251
12.6 Company Evaluation Quadrant: Start-Ups/Smes 252
12.6.1 Progressive Companies 252
12.6.2 Starting Blocks 252
12.6.3 Responsive Companies 252
12.6.4 Dynamic Companies 252
Figure 40 Drug Discovery Services Market: Company Evaluation Quadrant For Start-Ups/Smes, 2022 253
12.7 Company Footprint Analysis 254
12.7.1 Company Service Footprint 254
Table 286 Service Portfolio Analysis: Drug Discovery Services Market (2022) 254
12.7.2 Company Geographic Footprint 255
Table 287 Geographic Revenue Mix: Drug Discovery Services Market (2022) 255
12.8 Competitive Scenario 256
Table 288 Drug Discovery Services Market: Service Launches,January 2020–March 2023 256
Table 289 Drug Discovery Services Market: Deals, January 2020–March 2023 257
Table 290 Drug Discovery Services Market: Expansion: January 2020–March 2023 258

13 Company Profiles 259
13.1 Key Players 259
(Business Overview, Products/Services/Solutions Offered, Mnm View, Key Strengths And Right To Win, Strategic Choices Made, Weaknesses And Competitive Threats, Recent Developments)*
13.1.1 Laboratory Corporation Of America Holdings 259
Table 291 Laboratory Corporation Of America Holdings: Business Overview 259
Figure 41 Laboratory Corporation Of America Holdings: Company Snapshot (2022) 260
13.1.2 Charles River Laboratories International, Inc. 263
Table 292 Charles River Laboratories International: Business Overview 263
Figure 42 Charles River Laboratories International: Company Snapshot (2022) 264
13.1.3 Wuxi Apptec 270
Table 293 Wuxi Apptec: Business Overview 270
Figure 43 Wuxi Apptec: Company Snapshot (2021) 271
13.1.4 Thermo Fisher Scientific 275
Table 294 Thermo Fisher Scientific: Business Overview 275
Figure 44 Thermo Fisher Scientific Inc: Company Snapshot (2022) 276
13.1.5 Pharmaron Beijing Co., Ltd. 279
Table 295 Pharmaron Beijing Co., Ltd.: Business Overview 279
Figure 45 Pharmaron Beijing Co., Ltd.: Company Snapshot (2021) 280
13.1.6 Evotec Se 285
Table 296 Evotec Se: Business Overview 285
Figure 46 Evotec Se: Company Snapshot (2021) 286
13.1.7 Eurofins Scientific Se 293
Table 297 Eurofins Scientific Se: Business Overview 293
Figure 47 Eurofins Scientific Se: Company Snapshot (2022) 293
13.1.8 Piramal Enterprises Limited 300
Table 298 Piramal Enterprises Limited: Business Overview 300
Figure 48 Piramal Enterprises Limited: Company Snapshot (2021) 301
13.1.9 Syngene International Limited 303
Table 299 Syngene International Limited: Business Overview 303
Figure 49 Syngene International Limited: Company Snapshot (2021) 303
13.1.10 Curia Global Inc. 307
Table 300 Curia Global Inc.: Business Overview 307
13.1.11 Genscript Biotech Corporation 310
Table 301 Genscript Biotech Corporation: Business Overview 310
Figure 50 Genscript Biotech Corporation: Company Snapshot (2021) 311
13.1.12 Jubilant Pharmova Limited 313
Table 302 Jubilant Pharmova Limited: Business Overview 313
Figure 51 Jubilant Pharmova Limited: Company Snapshot (2021) 314
13.1.13 Frontage Holdings Corporation 317
Table 303 Frontage Holdings Corporation: Business Overview 317
Figure 52 Frontage Holdings Corporation: Company Snapshot (2021) 318
13.1.14 Shanghai Medicilon Inc. 321
Table 304 Shanghai Medicilon Inc.: Business Overview 321
13.1.15 Aurigene Discovery Technologies(Dr. Reddy’s Laboratories) 323
Table 305 Dr. Reddy’s Laboratories Ltd.: Business Overview 323
Figure 53 Dr. Reddy’s Laboratories Ltd.: Company Snapshot (2021) 324
13.1.16 Sygnature Discovery Ltd. 326
Table 306 Sygnature Discovery Ltd: Business Overview 326
13.1.17 Oncodesign Services 330
Table 307 Oncodesign Services: Business Overview 330
Figure 54 Oncodesign Services: Company Snapshot (2021) 331
*Business Overview, Products/Services/Solutions Offered, Mnm View, Key Strengths And Right To Win, Strategic Choices Made, Weaknesses And Competitive Threats, Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
13.2 Other Companies 333
13.2.1 Selvita S.A. 333
13.2.2 Viva Biotech Holdings 334
13.2.3 Tcg Lifesciences Pvt Ltd. 335
13.2.4 Shanghai Chempartner Co., Ltd. 335
13.2.5 Domainex Ltd. 336
13.2.6 Nuvisan Pharma Holding Gmbh 337
13.2.7 Dalton Pharma Services 338
13.2.8 Aragen Life Sciences Pvt. Ltd. 339
13.2.9 Promega Corporation 339

14 Appendix 340
14.1 Discussion Guide 340
14.2 Knowledge Store: Marketsandmarkets’subscription Portal 344
14.3 Customization Options 346
14.4 Related Reports 346
14.5 Author Details 347

  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs